Bayer HealthCare / U.S. FDA Approves Xarelto® (Rivaroxaban) to Treat Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) as well as to Reduce the Risk of Recurrent Events
Information on our manufacturing and research sites as well as the homepages of our BHC subsidiaries in the countries.
Information on structures of Bayer HealthCare AG.
Information about the research focus in our divisions.
Publications by Bayer and Bayer HealthCare - online versions, downloads and orders.
Find the Bayer HealthCare press archive, including all press releases and background materials. p>
Please catch up here on current international events related to different health care topics.
Further health care links
Please find here our media contacts.
Please confirm that you are a medical journalist. This website is intended to provide information to an international audience outside the USA and UK. Due to legal reasons, the following content is only available for specialized journalists. To access these pages, please confirm that you are a medical journalist and that you would like to accredit to the Bayer HealthCare press portal.
Font size
Select Country Andina Region Argentina Cono Sur Austria (d) Australia Belgium Brazil Canada Chile China Central America Denmark (Bayer Norden) Finland France Germany Great Britain/Ireland Greece Italy Japan Korea Mexico Netherlands New Zealand Norway Poland Russia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey Uruguay Bayer Cono Sur USA